非心脏手术对已安装冠脉内药物涂层支架患者预后影响.docVIP

非心脏手术对已安装冠脉内药物涂层支架患者预后影响.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
非心脏手术对已安装冠脉内药物涂层支架患者预后影响

非心脏手术对已安装冠脉内药物涂层支架患者预后影响[摘要] 目的:观察非心脏手术对已安装冠脉内药物涂层支架患者预后的影响。方法:收集2007年1月~2009年12月安装冠脉内药物涂层支架后接受过非心脏手术的患者60例,其中27例患者在安装支架后12个月内手术(A组),33例在安装支架后12个月后手术(B组)。另外,随机选择安装冠脉内药物涂层支架,但其后未接受过手术的患者30例作为对照(C组)。观察术后1年内(A组和B组)或安装支架后1年内(C组)主要不良心脑血管事件(MACCE)的发生情况。结果:A组的MACCE发生率显著高于C组(P0.05)。结论:在安装冠脉内药物涂层支架后的双抗期接受非心脏手术严重影响患者预后,非急诊手术宜在双重抗凝的12个月以后进行。 [关键词] 药物涂层支架;非心脏手术;预后 [中图分类号] R654.2[文献标识码]A [文章编号]1673-7210(2011)07(c)-031-02 The effect of noncardiac surgery on the prognosis of the patients received drug-eluting stent implantation ZHAO Huijun1, FAN Weixing1, CHEN Changbao2, WANG Aizhong2* 1.Department of Internal Medicine, the Fourth People′s Hospital of Jiaozuo City, He’nan Province, Jiaozuo 454000, China; 2.Department of Anesthesiology, the Affiliated Sixth People′s Hospital of Shanghai Jiao Tong University, Shanghai 200233, China [Abstract] Objective: To evaluate the effect of noncardiac surgery on the prognosis of the patients having received drug-eluting stent implantation. Methods: 60 patients who had received a noncardiac surgy after drug-eluting stent implantation were recruited between January 2007 to December 2008, 27 of them received a surgery during the dual antiplatelet treatment (12 months after stent implantation) (group A), and 33 of them received a surgery after the dual antiplatelet treatment (group B). 30 patients who did not receive any surgery after stent implantation were also recuited (group C).Main cardio-cerebral vascular events (MACCE)were recorded within one year after surgery (group A and group B) or after stenting (group C). Results: The incidence of MACCE was higher in group A than in group C (P0.05). Conclusion: A noncardiac surgery during the dual antiplatelet treatment might have an adversary effect on the prognosis of the patients after drug-eluting stent implantation. An elective surgery should be carried out after 12 months of the dual antiplatelet treatment. [Key words] Drug-eluting stent; Noncardiac surgery; Prognosis 药物涂层

文档评论(0)

docman126 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:7042123103000003

1亿VIP精品文档

相关文档